Cow's milk protein, beta-casein, comes in A1 and A2 forms, with different cow breeds producing varying amounts. While regular milk contains both, A2 milk has only the A2 type. Some studies suggest A2 ...

Details about the R2 remain limited. There have been no test mule sightings or official confirmations regarding its engine configuration, hardware, or launch timeline. For now, the trademark filing is ...

Yamaha Motor Co., Ltd. Have confirmed that the YZR-M1 machines will be powered by the V4 engine from the 2026 season onwards. This decision aligns with Yamaha's intentions to transition, underlining ...

Curran Simpson, President and CEO, highlighted strong momentum in late-stage gene therapy programs, emphasizing the progress of RGX-202 for Duchenne muscular dystrophy, RGX-121 for MPS II (Hunter ...

Yamaha Announces All-New Adventure-Ready WR125R Dual Sport Yamaha’s all-new entry-level WR125R makes the thrill of dual sport riding accessible to riders of all skill levels with versatile all-terrain ...

Why you can trust What Hi-Fi? Our expert team reviews products in dedicated test rooms, to help you make the best choice for your budget. Find out more about how we test. If you’re a fan of soundbars, ...

The instant you see the all-new CrossWave, you realize it's not your average personal watercraft (PWC, i.e. jet ski), even though it's technically part of Yamaha's WaveRunner PWC lineup. It's really a ...

Curran M. Simpson, President and CEO, announced, "We are accelerating our guidance for RGX-202. We now expect to complete enrollment in the ongoing pivotal study this October." Simpson stated that ...

REGENXBIO Inc. (NASDAQ:RGNX) is one of the biotech stocks to buy according to Wall Street analysts. On July 10, REGENXBIO announced the publication of preclinical results for its investigational gene ...

RGX-202 demonstrated significant functional improvements in DMD patients, surpassing natural history controls in key assessments like the North Star Ambulatory Assessment. High microdystrophin ...

Favorable safety profile continues with no serious adverse events or adverse events of special interest observed Webcast to be held at 8:00 a.m. today ROCKVILLE, Md., June 5, 2025 /PRNewswire/ -- ...